Skip to contentWestphal Christoph H — Sirtris Pharmaceuticals, Inc. insider: 357 transactions · InsiderLensWestphal Christoph H
- Director at Sirtris Pharmaceuticals, Inc. · on record since May 31, 2007
- President and CEO at Sirtris Pharmaceuticals, Inc. · on record since May 31, 2007
- Director at ALNYLAM PHARMACEUTICALS, INC. · on record since May 27, 2004
- 10% owner at ALNYLAM PHARMACEUTICALS, INC. · on record since May 27, 2004
- Director at MOMENTA PHARMACEUTICALS INC · on record since Jun 23, 2004
- Director at Verastem, Inc. · on record since Jan 26, 2012
- 10% owner at Verastem, Inc. · on record since Jan 26, 2012
- Director at Tempest Therapeutics, Inc. · on record since Jun 11, 2012
- 10% owner at Tempest Therapeutics, Inc. · on record since Jun 11, 2012
- Executive Chairman at Verastem, Inc. · on record since Mar 31, 2014
- Director at Flex Pharma, Inc. · on record since Jan 28, 2015
- President and CEO at Flex Pharma, Inc. · on record since Jan 28, 2015
- 10% owner at Flex Pharma, Inc. · on record since Apr 29, 2015
- 10% owner at TScan Therapeutics, Inc. · on record since Jul 22, 2021
- Director at TScan Therapeutics, Inc. · on record since Jul 15, 2021
Insider trading activity of Westphal Christoph H
- Transactions on record
- 357
- since Jun 1, 2004
- Open-market buys
- 102
- $17.3M
- Open-market sells
- 114
- $3.7M
- Companies traded
- 7
- last filing Jul 22, 2021
Figures computed from official regulatory filings — methodology.
Companies where Westphal Christoph H has traded
- TScan Therapeutics, Inc.5 tx · $2M · Jul 22, 2021
- Flex Pharma, Inc.90 tx · $9.1M · Dec 21, 2018
- Verastem, Inc.82 tx · $15.2M · Jul 1, 2015
- Tempest Therapeutics, Inc.7 tx · $1.1M · Mar 11, 2014
- Sirtris Pharmaceuticals, Inc.123 tx · $864.7K · May 30, 2008
- MOMENTA PHARMACEUTICALS INC35 tx · May 27, 2005
- ALNYLAM PHARMACEUTICALS, INC.15 tx · Jun 7, 2004
Track record of Westphal Christoph H
Statistical track record
Free- Open-market buys
- 102
- Last buy
- Jul 20, 2021
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of Westphal Christoph H
Co-insiders of Westphal Christoph H
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
Atlas Venture Associates VI, L.P.ALNYLAM PHARMACEUTICALS, INC. +1
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jul 22, 2021 | OtherD | -641,848 | — | — | SEC |
| Jul 22, 2021 | OtherD | -332,594 | — | — | SEC |
| Jul 22, 2021 | Other | 1,145,505 | — | — | SEC |
| Jul 22, 2021 | Buy | 133,333 | 15.00 USD | $2M | SEC |
| Jul 22, 2021 | OtherD | -171,063 | — | — | SEC |
| Dec 21, 2018 | Gift | -858,300 | 0.00 USD | $0 | SEC |
| Dec 21, 2018 | Gift | -2,200,000 | 0.00 USD | $0 | SEC |
| Oct 18, 2018 | Sell | -3,212,861 | 0.92 USD | $3M | SEC |
| Jul 27, 2017 | AwardD | 12,000 | 0.00 USD | $0 | SEC |
| Nov 8, 2016 | Buy | 7,000 | 7.31 USD | $51.2K | SEC |
| Nov 7, 2016 | Buy | 8,870 | 5.70 USD | $50.6K | SEC |
| Jun 24, 2016 | Buy | 2,700 | 11.28 USD | $30.5K | SEC |
| Jun 22, 2016 | Buy | 2,900 | 11.03 USD | $32K | SEC |
| Jun 22, 2016 | Buy | 2,800 | 11.07 USD | $31K | SEC |
| Jun 21, 2016 | Buy | 3,000 | 11.37 USD | $34.1K | SEC |
| Jun 21, 2016 | Buy | 3,000 | 10.98 USD | $32.9K | SEC |
| Jun 17, 2016 | Buy | 2,900 | 11.24 USD | $32.6K | SEC |
| Jun 17, 2016 | Buy | 2,900 | 11.10 USD | $32.2K | SEC |
| Jun 15, 2016 | Buy | 2,900 | 11.90 USD | $34.5K | SEC |
| Jun 15, 2016 | Buy | 3,000 | 11.19 USD | $33.6K | SEC |
| Jun 13, 2016 | Buy | 3,000 | 11.83 USD | $35.5K | SEC |
| Jun 13, 2016 | Buy | 3,000 | 12.04 USD | $36.1K | SEC |
| Jun 9, 2016 | Buy | 3,000 | 12.26 USD | $36.8K | SEC |
| Jun 9, 2016 | Buy | 2,900 | 12.24 USD | $35.5K | SEC |
| Jun 7, 2016 | Buy | 3,000 | 12.33 USD | $37K | SEC |